TS ELECTRONICS, INC. INDEX TO FINANCIAL STATEMENTS ONNY INVESTMENT LIMITED AND SUBSIDIARY REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM......................F-2 BALANCE SHEETS...................................

AUDITED FINANCIAL STATEMENTS

TS ELECTRONICS, INC.

INDEX TO FINANCIAL STATEMENTS

ONNY INVESTMENT LIMITED AND SUBSIDIARY

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM......................F-2

BALANCE SHEETS...............................................................F-3

STATEMENTS OF OPERATIONS.....................................................F-4

STATEMENTS OF STOCKHOLDER'S EQUITY...........................................F-4

STATEMENTS OF CASH FLOWS.....................................................F-5

NOTES........................................................................F-6

HAINAN HELPSON MEDICINE & BIOTECHNIQUE CO., LTD.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.....................F-15

Balance Sheets..............................................................F-16

Statements of Operations....................................................F-17

Statements of Stockholders' Equity..........................................F-18

Statements of Cash Flows....................................................F-19

NOTES.......................................................................F-20

TS ELECTRONICS, INC.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.....................F-28

Report of Independent Registered Public Accounting Firm.....................F-29

Balance Sheets..............................................................F-30

Statements of Operations....................................................F-31

Statements of Changes in Stockholders' Deficit..............................F-32

Statements of Cash Flows....................................................F-33

Notes.......................................................................F-34

[LETTERHEAD OF HANSEN, BARNETT & MAXWELL]

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and the Shareholder

Onny Investment Limited

We have audited the accompanying balance sheet of Onny Investment Limited, a

development stage enterprise, as of May 31, 2005, and the related statement of

operations, stockholder's equity, and cash flows for the period January 12, 2005

(date of inception) through May 31, 2005. These financial statements are the

responsibility of the Company's management. Our responsibility is to express an

opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company

Accounting Oversight Board (United States). Those standards require that we plan

and perform the audit to obtain reasonable assurance about whether the financial

statements are free of material misstatement. An audit includes examining, on a

test basis, evidence supporting the amounts and disclosures in the financial

statements. An audit also includes assessing the accounting principles used and

significant estimates made by management, as well as evaluating the overall

financial statement presentation. We believe that our audit provides a

reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in

all material respects, the financial position of Onny Investment Limited as of

May 31, 2005, and the results of its operations and its cash flows for the

period from January 12, 2005 (Date of Inception) through May 31, 2005, in

conformity with accounting principles generally accepted in the United States of

HANSEN, BARNETT & MAXWELL

Salt Lake City, Utah

August 1, 2005, except for Note 12,

As to which the date is October 19, 2005

See accompanying notes to the financial statements.

ONNY INVESTMENT LIMITED AND SUBSIDIARY

STATEMENTS OF STOCKHOLDER'S EQUITY

See accompanying notes to the financial statements.

See accompanying notes to the financial statements.

ONNY INVESTMENT LIMITED AND SUBSIDIARY

Notes to Financial Statements

(Information with Respect to June 30, 2005 and

for the Period from January 12, 2005 (Date of

Inception) through June 30, 2005 is Unaudited)

(Information in United States Dollars is Unaudited)

NOTE 1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

Organization - Onny Investment Limited ("Onny") was incorporated in the British

Virgin Islands on January 12, 2005. Through June 15, 2005, Onny was a

development stage enterprise with no development stage activities except for the

acquisition of Hainan Helpson, as discussed below. Upon the acquisition of

Hainan Helpson and its operations, Onny emerged from the development stage.

On April 12, 2005, Onny issued 100 shares of common stock to Tusi Hueng Mei

("Ms. Mei") in exchange for Y8 in cash. Ms. Mei also elected herself as Onny's

On June 16, 2005, the Company acquired all the outstanding shares of Hainan

Helpson Medical Biotechnology Co., Ltd (Hainan). See Note 2.

Hainan, formerly Hainan Fulin International Biomedical Industrial Co., Ltd., was

incorporated as a privately foreign and Chinese held joint venture between

Haikou Biomedical Engineering Co., Ltd. and Fordisland Development, Ltd. in

Hainan Province, People's Republic of China (PRC), on February 25, 1993.

Fordisland Development held a 30% interest in the Company and Haikou Biomedical

Engineering held a 70% interest in the Company. In July 1999, the Company

changed its name to Hainan Helpson Medicine & Biotechnique Co., Ltd.

In October 2001, Fordisland Development transferred its 30% interest in the

Company to Hainan Kaidi Technique Co. Ltd. and the Company changed its

organization status to a wholly Chinese owned enterprise.

Nature of Operations - Hainan manufactures and markets several Western and

Chinese medicines sold mainly to hospitals and private sellers in PRC, through

its marketing department in Hainan Province and from nine sales representative

offices in other provinces and cities. Hainan's other operating activities

include biochemical products, health products, and cosmetics.

Basis of Presentation and Translating Financial Statements - The accompanying

financial statements have been prepared in accordance with accounting principles

generally accepted in the United States of America. The Company's functional

currency is the Chinese Yuan (Renminbi) and the accompanying financial

statements have been expressed in Chinese Yuan. The financial statements as of

and for the period ended June 30, 2005 have been translated into United States

dollars solely for the convenience of the reader and are unaudited. Solely for

this purpose, the financial statements have been translated into U.S. dollars at

the rate of Y8.2765 = US $1.00, the approximate exchange rate prevailing on June

30, 2005. The translated United States dollar amounts should not be construed as

representing Chinese Yuan amounts or that the Yuan amounts have been or could be